Form D · Other
Filtravate, Inc.
Las Cruces, NM · CIK 0001859262
Offering snapshot reported Feb 17, 2022 · SEC filing
- Reported sold
- $60K Offering amount: $200K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 16, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 17, 2022 | Initial | $60,000 | No comparison | 1 | SEC filing |
| Apr 28, 2021 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-433981
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None |
Source: Form D, filed Feb 17, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Calvin Goforth | Director |
| Yun Li | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
3655 Research Rd
Las Cruces, NM, 88003
Las Cruces, NM, 88003